Literature DB >> 21704597

Magnetoliposomes with high USPIO entrapping efficiency, stability and magnetic properties.

Athanasios Skouras1, Spyridon Mourtas, Eleni Markoutsa, Marie-Christine De Goltstein, Claire Wallon, Sarah Catoen, Sophia G Antimisiaris.   

Abstract

The DRV technique (followed by extrusion) was used for construction of hydrophilic-USPIO encapsulating liposomes. Magnetoliposomes (ML) were characterized for size, surface charge, entrapment, physical stability and magnetic properties (relaxivity). Results show that nanosized extruded-DRV MLs encapsulate higher amounts of USPIOs in comparison with sonicated vesicles. Fe (III) encapsulation efficiency (EE) is 12%, the highest reported to date for nanosized MLs. EE of MLs is influenced by ML membrane composition and polyethyleneglycol (PEG) coating. PEG-coating increases ML EE and stability; however, r(2)-to-r(1) ratios decrease (in comparison with non-PEGylated MLs). Most ML-types are efficient T2 contrast agents (because r(2)-to-r(1) ratios are higher than that of free USPIOs). Targeted MLs were formed by successfully immobilizing OX-26 monoclonal antibody on ML surface (biotin-streptavidin ligation), without significant loss of USPIOs. Targeted MLs retained their nanosize and integrity during storage for 1 month at 4 °C and up to 2 weeks at 37 °C.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704597     DOI: 10.1016/j.nano.2011.06.010

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  17 in total

1.  Low-dose chemotherapy of hepatocellular carcinoma through triggered-release from bilayer-decorated magnetoliposomes.

Authors:  Yanjing Chen; Yuan Chen; Da Xiao; Arijit Bose; Ruitang Deng; Geoffrey D Bothun
Journal:  Colloids Surf B Biointerfaces       Date:  2014-01-25       Impact factor: 5.268

Review 2.  Nanotechnology in bone tissue engineering.

Authors:  Graham G Walmsley; Adrian McArdle; Ruth Tevlin; Arash Momeni; David Atashroo; Michael S Hu; Abdullah H Feroze; Victor W Wong; Peter H Lorenz; Michael T Longaker; Derrick C Wan
Journal:  Nanomedicine       Date:  2015-03-16       Impact factor: 5.307

3.  Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes.

Authors:  Daniela Frascione; Clemens Diwoky; Gunter Almer; Peter Opriessnig; Caroline Vonach; Kerstin Gradauer; Gerd Leitinger; Harald Mangge; Rudolf Stollberger; Ruth Prassl
Journal:  Int J Nanomedicine       Date:  2012-05-09

4.  A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer.

Authors:  Li Deng; Xingfa Ke; Zhiying He; Daoqiu Yang; Hai Gong; Yingying Zhang; Xiaolong Jing; Jianzhong Yao; Jianming Chen
Journal:  Int J Nanomedicine       Date:  2012-09-19

5.  Intravenous magnetic nanoparticle cancer hyperthermia.

Authors:  Hui S Huang; James F Hainfeld
Journal:  Int J Nanomedicine       Date:  2013-07-17

6.  In situ precipitation: a novel approach for preparation of iron-oxide magnetoliposomes.

Authors:  Shudong Xia; Peng Li; Qiang Chen; Malik Armah; Xiaoying Ying; Jian Wu; Jiangtao Lai
Journal:  Int J Nanomedicine       Date:  2014-05-23

7.  Stable cerasomes for simultaneous drug delivery and magnetic resonance imaging.

Authors:  Zhong Cao; Wenjian Zhu; Wei Wang; Chunyang Zhang; Ming Xu; Jie Liu; Shi-Ting Feng; Qing Jiang; Xiaoyan Xie
Journal:  Int J Nanomedicine       Date:  2014-11-05

Review 8.  Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.

Authors:  Sumit Arora
Journal:  Int J Nanomedicine       Date:  2012-07-06

9.  Effect of superparamagnetic iron oxide nanoparticles on fluidity and phase transition of phosphatidylcholine liposomal membranes.

Authors:  Poornima Budime Santhosh; Barbara Drašler; Damjana Drobne; Mateja Erdani Kreft; Slavko Kralj; Darko Makovec; Nataša Poklar Ulrih
Journal:  Int J Nanomedicine       Date:  2015-09-29

10.  Magnetoliposomes loaded with poly-unsaturated fatty acids as novel theranostic anti-inflammatory formulations.

Authors:  Daniel Calle; Viviana Negri; Paloma Ballesteros; Sebastián Cerdán
Journal:  Theranostics       Date:  2015-02-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.